GFA
IMCR icon

Godfrey Financial Associates’s Immunocore IMCR Stock Holding History

Godfrey Financial Associates’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191 Hold
6
– – ﹤0.01% 1010
2026
Q1 		$181 Hold
6
– – ﹤0.01% 1018
2025
Q4 		$208 Buy
+6
New +$212 ﹤0.01% 971

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Godfrey Financial Associates's IMCR Position: Q2 2026 in Review

Godfrey Financial Associates held its Immunocore (IMCR) position steady in Q2 2026 at 6 shares worth $191. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

Godfrey Financial Associates first reported a position in IMCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $208 in Q4 2025. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Godfrey Financial Associates held 6 shares of Immunocore worth $191 as of Q2 2026.
  • Godfrey Financial Associates left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up ﹤0.01% of Godfrey Financial Associates's portfolio in Q2 2026, its #1010 holding.
  • Godfrey Financial Associates first reported a position in Immunocore in Q4 2025 and has held it in 3 quarters since.
  • Godfrey Financial Associates's Immunocore position peaked at $208 in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.